A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer

Abstract No biomarker can effectively screen for early gastric cancer (EGC). Players in the A disintegrin and metalloproteinase (ADAM)-natural killer group 2 member D (NKG2D) receptor axis may have a role for that. As a proof-of-concept pilot study, the expression of ADAM8, ADAM9, ADAM10, ADAM12, AD...

詳細記述

書誌詳細

主要な著者:	Sooyeon Oh, Sang-Soo Lee, Hoeyoung Jin, Seo-Hyeon Choi, Choong-Keun Cha, Jooho Lee, KyuBum Kwack, Sang Gyun Kim, Sang-Woon Choi
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Portfolio 2025-01-01
シリーズ:	Scientific Reports
主題:	ADAM12 ADAM17 ADAM10 Gastric cancer Biomarker
オンライン･アクセス:	https://doi.org/10.1038/s41598-024-84237-y
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!